VIR
Vir Biotechnology, Inc. Common StockstockNASDAQ
vir brings together cutting-edge innovations with leading scientific expertise and management to take on some of the world's most challenging infectious diseases for which solutions are non-existent or inadequate. vir seeks to take a new approach, using breakthroughs in immune programming to manipulate pathogen-host interactions. the company will take a multi-program, multi-platform approach to applying these breakthroughs, guided by rigorous science and driven by medical need.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 10.51 | 2026-09-28 | +6.34% | -4.616 |
| 1M | 11.39 | 2026-09-04 | -1.84% | 1.881 |
| 3M | 10.02 | 2026-07-06 | +11.54% | 1.245 |
| 6M | 9.06 | 2026-04-06 | +23.36% | 1.134 |
| 1Y | 5.73 | 2025-10-03 | +95.04% | 1.713 |
| 2Y | 7.74 | 2024-10-04 | +44.39% | — |
| 5Y | 34.04 | 2021-10-04 | -67.17% | 1.354 |
Vir Biotechnology, Inc. Common Stock (NASDAQ:VIR) stock price today is $11.18, and today's volume is 2,180,670. VIR is down 1.010% today. The 30 day average volume is 2.17M. VIR market cap is $1.89B with 169.22M shares outstanding.